Sangamo Therapeutics
SGMO
SGMO
182 hedge funds and large institutions have $315M invested in Sangamo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
-14
Holders Change %
-7.14%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
63
Reduced
60
Closed
30
Calls
$1.18M
Puts
$639K
Net Calls
+$542K
Net Calls Change
+$64K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$30.7M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$44.1M |
| 3 |
3
BlackRock
New York
|
$48.2M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$4.41M |
| 5 |
LFCM
5
Long Focus Capital Management
San Juan,
Puerto Rico
|
$3.37M |
